Tm4sf4 regulates critical biological pathways:
Cell Migration: Inhibits Rho-activated migration and actin organization in a ROCK-independent manner .
Pancreatic Development: Opposes Nkx2.2 activity by suppressing α/β-cell differentiation while promoting ε-cell fates in zebrafish models .
Cancer Progression: Enhances hepatocellular carcinoma (HCC) aggressiveness via mitochondrial dysfunction and oxidative phosphorylation .
Recombinant Tm4sf4 is utilized in:
Mechanistic Studies: Investigating tetraspanin-integrin interactions in cancer metastasis .
Drug Development: Preclinical evaluation of anti-TM4SF antibodies to block tumor growth .
Diagnostic Tools: Detection via flow cytometry (e.g., Alexa Fluor® 488-conjugated antibodies) .
Tm4sf4 is overexpressed in HCCs and correlates with poor prognosis :
| Dataset | TM4SF4 Expression (HCC vs. Normal) | Statistical Significance |
|---|---|---|
| TCGA (n=366) | 2.1-fold increase | |
| CNHPP (n=35) | 3.5-fold increase | |
| GSE14520 (n=225) | 4.2-fold increase |
Current research focuses on:
STRING: 10090.ENSMUSP00000029377
UniGene: Mm.26618
Transmembrane 4 L6 Family Member 4 (Tm4sf4) is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. The protein structure consists of four hydrophobic transmembrane domains, two extracellular loops, a small intracellular loop, and short intracellular amino and carboxy tails. This structural arrangement is characteristic of the tetraspanin superfamily, which comprises approximately 33 proteins localized in the plasma membrane . The protein is also referred to as intestine and liver tetraspan membrane protein (IL-TMP) in some literature .
Methodologically, researchers studying the structure of Tm4sf4 should consider:
Using predictive computational modeling to analyze transmembrane domains
Applying crystallography or cryo-EM techniques for detailed structural characterization
Employing epitope mapping to identify accessible domains for targeting
Tm4sf4 shows a highly restricted expression pattern in normal tissues. Based on multiple transcript datasets (FANTOM5, GTEx, and HPA), Tm4sf4 expression is predominantly detected in the gastrointestinal tract and pancreas, with minimal expression in other tissues . Immunohistochemistry data has confirmed this tissue-restricted expression pattern at the protein level.
Specifically, Tm4sf4 demonstrates:
High expression in intestinal epithelial cells and hepatocytes
Low or undetectable levels in critical organs such as brain, lung, heart, and kidney
Significantly lower expression in normal tissues compared to other tetraspanin family members
When designing experiments to study Tm4sf4 expression, researchers should:
Include appropriate tissue panels covering both high and low expressing tissues
Employ multiple detection methods (qPCR, western blot, IHC) for validation
Consider single-cell approaches to characterize cell-type specific expression patterns
Tm4sf4 plays several important roles in cellular physiology:
Regulation of cell adhesion: Tm4sf4 influences the adhesive properties of intestinal epithelial cells .
Modulation of cell proliferation: It mediates density-dependent cell proliferation, suggesting a role in contact inhibition and tissue homeostasis .
Signal transduction: Like other tetraspanins, Tm4sf4 mediates signal transduction events that regulate cell development, activation, growth, and motility .
To investigate these functions experimentally, researchers should consider:
Loss-of-function studies using siRNA or CRISPR-Cas9 approaches
Gain-of-function experiments with overexpression systems
Co-immunoprecipitation studies to identify binding partners
Tm4sf4 demonstrates significant differential expression between HCC and normal liver tissue across multiple independent datasets. Extensive multiomics analyses have established Tm4sf4 as one of the top-ranked cell surface targets highly expressed in HCC .
Expression comparison data from multiple datasets:
| Dataset | Sample Size | Significance |
|---|---|---|
| TCGA | n = 366 | p < 1 x 10^-6 compared to six other common HCC targets |
| GSE14520 | n = 225 | p < 0.01 compared to all seven common HCC targets |
| CNHPP | n = 35 | p < 1 x 10^-5 compared to four other targets |
| CHCC (proteomics) | n = 165 | p < 0.05 compared to four other protein targets |
When studying Tm4sf4 expression in HCC contexts, researchers should:
Include matched tumor/normal tissue pairs whenever possible
Validate transcript-level findings with protein-level measurements
Consider the influence of tumor heterogeneity through single-cell approaches
Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool for characterizing Tm4sf4 expression patterns across heterogeneous cell populations. Recent studies have employed the following methodological approaches:
Dimensionality reduction visualization: Uniform Manifold Approximation and Projection (UMAP) has been utilized to visualize Tm4sf4 expression gradients across cell populations .
Correlation analysis: Genes highly correlated with Tm4sf4 expression (r ≥ 0.6) can be identified in both HCC and normal liver tissues to infer function .
Bioinformatic processing:
Quality control filtering of cells and genes
Normalization of expression values
Identification of highly variable genes
Principal component analysis
Clustering algorithms to identify discrete cell populations
Differential expression analysis across clusters
Researchers planning scRNA-seq experiments should:
Ensure adequate cell number capture from relevant populations
Include appropriate controls
Consider complementing with spatial transcriptomics for tissue context
Validate key findings with orthogonal methods like FACS or immunofluorescence
Tm4sf4 possesses several characteristics that make it an attractive target for immunotherapy development, particularly CAR T cell approaches against HCC:
Restricted normal tissue expression: Tm4sf4 shows minimal expression in critical organs (brain, lung, heart, kidney), reducing potential for on-target, off-tumor toxicity .
Favorable comparison to existing targets: Expression analysis across multiple datasets demonstrates that Tm4sf4 has a more favorable expression profile than seven other common HCC therapeutic targets (CD24, CD133/PROM1, CD147/BSG, EPCAM, GPC3, MET, and MUC1), with lower expression in normal tissues but higher expression in HCC cases .
Cell surface localization: As a tetraspanin family member, Tm4sf4 is localized to the plasma membrane, making it accessible to antibody-based therapeutic approaches .
When evaluating Tm4sf4 as an immunotherapy target, researchers should:
Assess binding accessibility of the extracellular domains
Evaluate potential cross-reactivity with other tetraspanin family members
Confirm expression patterns in preclinical models
Production of high-quality recombinant Tm4sf4 protein requires careful consideration of several factors:
Expression system selection:
Construct design:
Inclusion of appropriate tags (His, FLAG, etc.) for purification and detection
Consideration of signal peptides for proper membrane insertion
Potential modification of hydrophobic domains for improved expression
Purification strategies:
Detergent selection is critical for maintaining protein structure and function
Two-step purification (affinity chromatography followed by size exclusion) is recommended
Quality control by SDS-PAGE and western blotting is essential
Researchers should validate recombinant protein functionality through binding assays or functional tests to ensure the protein maintains its native properties.
As a tetraspanin family member, Tm4sf4 likely functions through interactions with other membrane proteins and signaling molecules. Several methodological approaches are suitable for investigating these interactions:
Co-immunoprecipitation (Co-IP):
Requires careful detergent selection to maintain tetraspanin-enriched microdomains
Crosslinking approaches may help capture transient interactions
Validation with reverse Co-IP is recommended
Proximity labeling techniques:
BioID or APEX2 fusion constructs can identify proximal proteins in living cells
TurboID offers faster labeling kinetics for capturing dynamic interactions
Functional interaction assays:
Bimolecular fluorescence complementation (BiFC)
Förster resonance energy transfer (FRET) microscopy
Mammalian two-hybrid systems
When analyzing protein interaction data, researchers should consider:
Distinguishing direct from indirect interactions
Validation across multiple experimental systems
Confirmation in physiologically relevant contexts
To understand the functional impact of Tm4sf4 in biological systems, researchers should consider multiple complementary approaches:
Gene expression modulation strategies:
CRISPR-Cas9 knockout for complete loss-of-function
siRNA or shRNA for transient knockdown
Overexpression systems with inducible control
Domain-specific mutants to pinpoint functional regions
Functional readouts:
Proliferation assays (especially density-dependent growth)
Adhesion assays to various substrates
Migration and invasion assays
Signaling pathway activation (particularly those associated with tetraspanins)
In vivo approaches:
Conditional knockout mouse models
Patient-derived xenograft models for HCC studies
Orthotopic models to maintain tissue microenvironment context
Multi-omics analysis of Tm4sf4 requires integration of data from various platforms:
Transcriptomic analysis:
Differential expression analysis between conditions
Co-expression network analysis to identify functionally related genes
Pathway enrichment analysis of correlated genes
Proteomic integration:
Correlation of transcript and protein expression levels
Analysis of post-translational modifications
Protein-protein interaction network construction
Advanced analytical approaches:
For example, GO enrichment analysis of genes highly correlated with Tm4sf4 expression in HCC has revealed functional associations with specific biological processes, providing insight into its role in cancer development .
When evaluating Tm4sf4 as a therapeutic target relative to alternatives, researchers should implement a systematic comparative framework:
Comprehensive expression comparison:
Analysis across multiple independent datasets
Inclusion of both transcript and protein-level data
Evaluation in both normal tissues and disease states
Target ranking methodology:
Visualization approaches:
Violin plots arranged by median expression values to facilitate comparison
Box-and-whisker plots with statistical significance indicators
Heatmaps showing expression across multiple tissues and targets simultaneously
For example, one study employed a composite ranking approach that integrated both transcript and protein expression data across multiple independent datasets to identify Tm4sf4 as the top-ranked target (x̄TP: 0.938) among eight shortlisted candidates for HCC .
When designing experiments to study Tm4sf4 expression patterns:
Developmental time course considerations:
Include multiple developmental stages
Consider both embryonic and postnatal timepoints
Analyze in the context of tissue differentiation
Disease progression analysis:
Include samples representing different disease stages
Consider inclusion of pre-malignant conditions
Analyze in relation to clinical outcomes
Technical and analytical considerations:
Select appropriate housekeeping genes for normalization
Consider splice variant analysis
Implement robust statistical approaches for small sample sizes
Use appropriate visualization methods for complex expression patterns